Maybe it will develop along the lines of an indicator of the effectiveness of treatment, with the aim of curtailing treatment that is no longer needed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025